2018/2019 ICD-10-CM Diagnosis Code C11.9. Malignant neoplasm of nasopharynx, unspecified. C11.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Personal history of malignant neoplasm of other organs and systems. Z85.89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM Z85.89 became effective on October 1, 2019.
| ICD-10 from 2011 - 2016 Z85.818 is a billable ICD code used to specify a diagnosis of personal history of malignant neoplasm of other sites of lip, oral cavity, and pharynx. A 'billable code' is detailed enough to be used to specify a medical diagnosis. POA Indicators on CMS form 4010A are as follows:
Personal history of other malignant neoplasm of skin. Z85.828 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM Z85.828 became effective on October 1, 2018.
Personal history of malignant neoplasm of nasal cavities, middle ear, and accessory sinuses. Z85. 22 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z85.
C11. 9 - Malignant neoplasm of nasopharynx, unspecified. ICD-10-CM.
ICD-10 code Z85 for Personal history of malignant neoplasm is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
G8921Chronic pain due to traumaG8922Chronic post-thoracotomy painG8928Other chronic postprocedural painG8929Other chronic painG893Neoplasm related pain (acute) (chronic)247 more rows
Nasopharyngeal cancer is a type of head and neck cancer. It starts in the nasopharynx, the upper part of the throat behind the nose and near the base of skull. Cancer starts when cells begin to grow out of control.
ICD-10 Code for Malignant neoplasm of head, face and neck- C76. 0- Codify by AAPC.
ICD-10 code: Z08 Follow-up examination after treatment for malignant neoplasm.
k. Code C80. 1, Malignant (primary) neoplasm, unspecified, equates to Cancer, unspecified. This code should only be used when no determination can be made as to the primary site of a malignancy.
21.8 explains that when using a history code, such as Z85, we also must use Z08 Encounter for follow-up examination after completed treatment for a malignant neoplasm. This follow-up code implies the condition is no longer being actively treated and no longer exists.
G51. 2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Code G89. 3 [Neoplasm related pain (acute) (chronic)] is listed as a secondary diagnosis.
(NEE-oh-PLA-zum) An abnormal mass of tissue that forms when cells grow and divide more than they should or do not die when they should. Neoplasms may be benign (not cancer) or malignant (cancer). Benign neoplasms may grow large but do not spread into, or invade, nearby tissues or other parts of the body.
ICD-10 code Z92. 21 for Personal history of antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Personal history codes may be used in conjunction with follow-up codes and family history codes may be used in conjunction with screening codes to explain the need for a test or procedure. History codes are also acceptable on any medical record regardless of the reason for visit.
History codes (Z77-Z99) may be necessary when the historical condition has an impact on current care or if the condition influences treatment. Capstone Performance Systems advises providers to document “History of” only when the condition no longer exists and it is not being treated or addressed.
Z85. 3 can be billed as a primary diagnosis if that is the reason for the visit, but follow up after completed treatment for cancer should coded as Z08 as the primary diagnosis.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
tobacco use ( Z72.0) Malignant neoplasm of nasopharynx. Approximate Synonyms. Cancer of the nasopharynx. Cancer of the nasopharynx, adenocarcinoma. Cancer of the nasopharynx, adenoid cystic. Cancer of the nasopharynx, squamous cell. Cancer of the nasopharynx, undifferentiated. Primary adenocarcinoma of nasopharynx.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
DRG Group #011-013 - Tracheostomy for face, mouth and neck diagnoses with MCC.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code Z85.818. Click on any term below to browse the alphabetical index.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code Z85.818 and a single ICD9 code, V10.02 is an approximate match for comparison and conversion purposes.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion '), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous such as tumors in different quadrants of the same breast, codes for each site should be assigned.
When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy at that site, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.
Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. Certain benign neoplasms , such as prostatic adenomas, may be found in the specific body system chapters. To properly code a neoplasm, it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. If malignant, any secondary ( metastatic) sites should also be determined.
Code C80.0, Disseminated malignant neoplasm, unspecified, is for use only in those cases where the patient has advanced metastatic disease and no known primary or secondary sites are specified. It should not be used in place of assigning codes for the primary site and all known secondary sites.
When a pregnant woman has a malignant neoplasm, a code from subcategory O9A.1 -, malignant neoplasm complicating pregnancy, childbirth, and the puerperium, should be sequenced first, followed by the appropriate code from Chapter 2 to indicate the type of neoplasm. Encounter for complication associated with a neoplasm.
There are also codes Z85.6, Personal history of leukemia, and Z85.79, Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues. If the documentation is unclear as to whether the leukemia has achieved remission, the provider should be queried.
Code C80.1, Malignant ( primary) neoplasm, unspecified, equates to Cancer, unspecified. This code should only be used when no determination can be made as to the primary site of a malignancy. This code should rarely be used in the inpatient setting.